Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

Mini-Review Article

The Utilization and Development of Viral Vectors in Vaccines as a Prophylactic Treatment Against Ebola Virus as an Emerging and Zoonotic Infectious Disease

Author(s): Anthony Garcia* and Oliver Grundmann

Volume 24, Issue 3, 2024

Published on: 08 September, 2023

Page: [289 - 299] Pages: 11

DOI: 10.2174/1389557523666230725115324

Price: $65

Abstract

Alongside the prescription of commonly used antivirals, such as acyclovir, remdesivir, oseltamivir, and ciprofloxacin, the most efficient way to prevent or treat communicable diseases is by vaccination. Vaccines have been the most efficient way to prevent or treat highly transmissible infectious agents, such as Ebola, Anthrax, and Dengue Fever. Most epidemics of these highly transmissible infectious agents occur in places, such as South America, Central America, Tropical Asia, and Africa, where the availability of resources and access to adequate healthcare are limited. However, recent events in history have proven that even with access to resources and proper healthcare, those in firstworld countries are not invincible when it comes to infectious diseases and epidemics. The Ebola virus outbreak in West Africa highlighted the gaps in therapeutic advancement and readiness and led to the rapid development of novel vaccine approaches. Viral vectors, in the case of the Ebola vaccine the Vesicular Stomatitis Virus (VSV), can be safely used to activate or initiate the innate adaptive immune response to protect against viral infection. When developed properly and with extensive study, novel vaccine approaches allow physicians and health experts to control the rate at which viruses spread or prevent transmission. This review will discuss the advantages of viral vector vaccines, their chemistry and development, and the pathophysiology of the Ebola virus to develop advantageous and efficacious treatments.

Graphical Abstract

[1]
Li, W.; Liao, J.; Li, Q.; Baskota, M.; Wang, X.; Tang, Y.; Zhou, Q.; Wang, X.; Luo, X.; Ma, Y.; Fukuoka, T.; Ahn, H.S.; Lee, M.S.; Chen, Y.; Luo, Z.; Liu, E. Public health education for parents during the outbreak of COVID-19: A rapid review. Ann. Transl. Med., 2020, 8(10), 628-628.
[http://dx.doi.org/10.21037/atm-20-3312] [PMID: 32566565]
[2]
Duong, D. Endemic, not over: Looking ahead to a new COVID era. CMAJ, 2022, 194(39), E1358-E1359.
[3]
Kavulikirwa, O.K.; Sikakulya, F.K. Recurrent ebola outbreaks in the eastern democratic republic of the congo: A wake-up call to scale up the integrated disease surveillance and response strategy. One Health, 2022, 14, 100379.
[http://dx.doi.org/10.1016/j.onehlt.2022.100379] [PMID: 35313715]
[4]
Aruna, A.; Mbala, P.; Minikulu, L.; Mukadi, D.; Bulemfu, D.; Edidi, F.; Bulabula, J.; Tshapenda, G.; Nsio, J.; Kitenge, R.; Mbuyi, G.; Mwanzembe, C.; Kombe, J.; Lubula, L.; Shako, J.C.; Mossoko, M.; Mulangu, F.; Mutombo, A.; Sana, E.; Tutu, Y.; Kabange, L.; Makengo, J.; Tshibinkufua, F.; Ahuka-Mundeke, S.; Muyembe, J.J.; Cdc, E.R.; Alarcon, W.; Bonwitt, J.; Bugli, D.; Bustamante, N.D.; Choi, M.; Dahl, B.A.; DeCock, K.; Dismer, A.; Doshi, R.; Dubray, C.; Fitter, D.; Ghiselli, M.; Hall, N.; Ben Hamida, A.; McCollum, A.M.; Neatherlin, J.; Raghunathan, P.L.; Ravat, F.; Reynolds, M.G.; Rico, A.; Smith, N.; Soke, G.N.; Trudeau, A.T.; Victory, K.R.; Worrell, M.C. Ebola virus disease outbreak - democratic republic of the congo, August 2018-November 2019. MMWR Morb. Mortal. Wkly. Rep., 2019, 68(50), 1162-1165.
[http://dx.doi.org/10.15585/mmwr.mm6850a3] [PMID: 31856146]
[5]
Malvy, D.; McElroy, A.K.; de Clerck, H.; Günther, S.; van Griensven, J. Ebola virus disease. Lancet, 2019, 393(10174), 936-948.
[http://dx.doi.org/10.1016/S0140-6736(18)33132-5] [PMID: 30777297]
[6]
Mulangu, S.; Dodd, L.E.; Davey, R.T., Jr; Tshiani Mbaya, O.; Proschan, M.; Mukadi, D.; Lusakibanza, M.M.; Nzolo, D.; Tshomba, O.A.; Ibanda, A.; Ali, R.; Coulibaly, S.; Levine, A.C.; Grais, R.; Diaz, J.; Lane, H.C.; Muyembe-Tamfum, J.J.; Sivahera, B.; Camara, M.; Kojan, R.; Walker, R.; Dighero-Kemp, B.; Cao, H.; Mukumbayi, P.; Mbala-Kingebeni, P.; Ahuka, S.; Albert, S.; Bonnett, T.; Crozier, I.; Duvenhage, M.; Proffitt, C.; Teitelbaum, M.; Moench, T.; Aboulhab, J.; Barrett, K.; Cahill, K.; Cone, K.; Eckes, R.; Hensley, L.; Herpin, B.; Higgs, E.; Ledgerwood, J.; Pierson, J.; Smolskis, M.; Sow, Y.; Tierney, J.; Sivapalasingam, S.; Holman, W.; Gettinger, N.; Vallée, D.; Nordwall, J. A randomized, controlled trial of Ebola virus disease therapeutics. N. Engl. J. Med., 2019, 381(24), 2293-2303.
[http://dx.doi.org/10.1056/NEJMoa1910993] [PMID: 31774950]
[7]
Sissoko, D.; Laouenan, C.; Folkesson, E.; M’Lebing, A.B.; Beavogui, A.H.; Baize, S.; Camara, A.M.; Maes, P.; Shepherd, S.; Danel, C.; Carazo, S.; Conde, M.N.; Gala, J.L.; Colin, G.; Savini, H.; Bore, J.A.; Le Marcis, F.; Koundouno, F.R.; Petitjean, F.; Lamah, M.C.; Diederich, S.; Tounkara, A.; Poelart, G.; Berbain, E.; Dindart, J.M.; Duraffour, S.; Lefevre, A.; Leno, T.; Peyrouset, O.; Irenge, L.; Bangoura, N.F.; Palich, R.; Hinzmann, J.; Kraus, A.; Barry, T.S.; Berette, S.; Bongono, A.; Camara, M.S.; Chanfreau, M.V.; Doumbouya, L.; Souley, H.; Kighoma, P.M.; Koundouno, F.R.; Réné, L.; Loua, C.M.; Massala, V.; Moumouni, K.; Provost, C.; Samake, N.; Sekou, C.; Soumah, A.; Arnould, I.; Komano, M.S.; Gustin, L.; Berutto, C.; Camara, D.; Camara, F.S.; Colpaert, J.; Delamou, L.; Jansson, L.; Kourouma, E.; Loua, M.; Malme, K.; Manfrin, E.; Maomou, A.; Milinouno, A.; Ombelet, S.; Sidiboun, A.Y.; Verreckt, I.; Yombouno, P.; Bocquin, A.; Carbonnelle, C.; Carmoi, T.; Frange, P.; Mely, S.; Nguyen, V.K.; Pannetier, D.; Taburet, A.M.; Treluyer, J.M.; Kolie, J.; Moh, R.; Gonzalez, M.C.; Kuisma, E.; Liedigk, B.; Ngabo, D.; Rudolf, M.; Thom, R.; Kerber, R.; Gabriel, M.; Di Caro, A.; Wölfel, R.; Badir, J.; Bentahir, M.; Deccache, Y.; Dumont, C.; Durant, J.F.; El Bakkouri, K.; Gasasira, U.M.; Smits, B.; Toufik, N.; Van, C.S.; Ezzedine, K.; Dortenzio, E.; Pizarro, L.; Etienne, A.; Guedj, J.; Fizet, A.; Barte de, S.F.E.; Murgue, B.; Tran-Minh, T.; Rapp, C.; Piguet, P.; Poncin, M.; Draguez, B.; Allaford, D.T.; Barbe, S.; Baret, G.; Defourny, I.; Carroll, M.; Raoul, H.; Augier, A.; Eholie, S.P.; Yazdanpanah, Y.; Levy-Marchal, C.; Antierrens, A.; Van Herp, M.; Günther, S.; de Lamballerie, X.; Keïta, S.; Mentre, F.; Anglaret, X.; Malvy, D. Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): A historically controlled, single-arm proof-of-concept trial in Guinea. PLoS Med., 2016, 13(3), e1001967.
[http://dx.doi.org/10.1371/journal.pmed.1001967] [PMID: 26930627]
[8]
Guedj, J.; Piorkowski, G.; Jacquot, F.; Madelain, V.; Nguyen, T.H.T.; Rodallec, A.; Gunther, S.; Carbonnelle, C.; Mentré, F.; Raoul, H.; de Lamballerie, X. Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques. PLoS Med., 2018, 15(3), e1002535.
[http://dx.doi.org/10.1371/journal.pmed.1002535] [PMID: 29584730]
[9]
Tchesnokov, E.; Feng, J.; Porter, D.; Götte, M. Mechanism of inhibition of Ebola virus RNA-dependent RNA polymerase by remdesivir. Viruses, 2019, 11(4), 326.
[http://dx.doi.org/10.3390/v11040326] [PMID: 30987343]
[10]
Rojas, M.; Monsalve, D.M.; Pacheco, Y.; Acosta-Ampudia, Y.; Ramírez-Santana, C.; Ansari, A.A.; Gershwin, M.E.; Anaya, J.M. Ebola virus disease: An emerging and re-emerging viral threat. J. Autoimmun., 2020, 106, 102375.
[http://dx.doi.org/10.1016/j.jaut.2019.102375] [PMID: 31806422]
[11]
Gaudinski, M.R.; Coates, E.E.; Novik, L.; Widge, A.; Houser, K.V.; Burch, E.; Holman, L.A.; Gordon, I.J.; Chen, G.L.; Carter, C.; Nason, M.; Sitar, S.; Yamshchikov, G.; Berkowitz, N.; Andrews, C.; Vazquez, S.; Laurencot, C.; Misasi, J.; Arnold, F.; Carlton, K.; Lawlor, H.; Gall, J.; Bailer, R.T.; McDermott, A.; Capparelli, E.; Koup, R.A.; Mascola, J.R.; Graham, B.S.; Sullivan, N.J.; Ledgerwood, J.E.; Hendel, C.S.; Plummer, S.H.; Costner, P.; Saunders, J.; Mendoza, F.; Eshun, A.M.; Casazza, J.; Ola, A.; Whalen, W.; Wang, X.; Cunningham, J.; Vasilenko, O.; Boyd, C.R.; Trofymenko, O.; Burgos Florez, M.C.; Hickman, S.; Rothwell, R.S.; Pittman, I.R.; Le, L.N.; Larkin, B.D.; Cox, J.H.; Apte, P.J.; Hicks, R.T.; Trelles Cartagena, C.; Williams, P.V.; Requilman, L.S.; Nguyen, T.; Tran, C.; Vazquez, S.; Conan-Cibotti, M.; Stein, J.; Beresnev, T. Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): An open-label phase 1 study. Lancet, 2019, 393(10174), 889-898.
[http://dx.doi.org/10.1016/S0140-6736(19)30036-4] [PMID: 30686586]
[12]
Davey, R.T., Jr; Dodd, L.; Proschan, M.A.; Neaton, J.; Neuhaus, N.J.; Koopmeiners, J.S.; Beigel, J.; Tierney, J.; Lane, H.C.; Fauci, A.S.; Massaquoi, M.B.F.; Sahr, F.; Malvy, D. A randomized, controlled trial of ZMapp for Ebola virus infection. N. Engl. J. Med., 2016, 375(15), 1448-1456.
[http://dx.doi.org/10.1056/NEJMoa1604330] [PMID: 27732819]
[13]
Kennedy, S.B.; Bolay, F.; Kieh, M.; Grandits, G.; Badio, M.; Ballou, R.; Eckes, R.; Feinberg, M.; Follmann, D.; Grund, B.; Gupta, S.; Hensley, L.; Higgs, E.; Janosko, K.; Johnson, M.; Kateh, F.; Logue, J.; Marchand, J.; Monath, T.; Nason, M.; Nyenswah, T.; Roman, F.; Stavale, E.; Wolfson, J.; Neaton, J.D.; Lane, H.C. Phase 2 placebo-controlled trial of two vaccines to prevent Ebola in Liberia. N. Engl. J. Med., 2017, 377(15), 1438-1447.
[http://dx.doi.org/10.1056/NEJMoa1614067] [PMID: 29020589]
[14]
Bolay, F.K.; Grandits, G.; Lane, H.C.; Kennedy, S.B.; Johnson, M.P.; Fallah, M.P.; Wilson, B.; Njoh, W.S.; McNay, L.A.; Hensley, L.E.; Higgs, E.S. PREVAIL I cluster vaccination study with rVSVΔG-ZEBOV-GP as part of a public health response in Liberia. J. Infect. Dis., 2019, 219(10), 1634-1641.
[http://dx.doi.org/10.1093/infdis/jiy698] [PMID: 30561672]
[15]
Cross, R.W.; Mire, C.E.; Feldmann, H.; Geisbert, T.W. Post-exposure treatments for Ebola and Marburg virus infections. Nat. Rev. Drug Discov., 2018, 17(6), 413-434.
[http://dx.doi.org/10.1038/nrd.2017.251] [PMID: 29375139]
[16]
Balcioglu, M.; Rana, M.; Hizir, M.S.; Robertson, N.M.; Haque, K.; Yigit, M.V. Rapid visual screening and programmable subtype classification of ebola virus biomarkers. Adv. Healthc. Mater., 2017, 6(2), 1600739.
[http://dx.doi.org/10.1002/adhm.201600739] [PMID: 27990771]
[17]
Locke, M.; Lythe, G.; López-García, M.; Muñoz-Fontela, C.; Carroll, M.; Molina-París, C. Quantification of type I interferon inhibition by viral proteins: Ebola virus as a case study. Viruses, 2021, 13(12), 2441.
[http://dx.doi.org/10.3390/v13122441] [PMID: 34960709]
[18]
Moni, B.M.; Sakurai, Y.; Yasuda, J. Ebola virus GP activates endothelial cells via host cytoskeletal signaling factors. Viruses, 2022, 14(1), 142.
[http://dx.doi.org/10.3390/v14010142] [PMID: 35062347]
[19]
Fausther-Bovendo, H.; Qiu, X.; Babuadze, G.G.; Azizi, H.; Pedersen, J.; Wong, G.; Kobinger, G.P. Transient liver damage and hemolysis are associated with an inhibition of ebola virus glycoprotein-specific antibody response and lymphopenia. J. Infect. Dis., 2022, 225(10), 1852-1855.
[http://dx.doi.org/10.1093/infdis/jiab552] [PMID: 34791300]
[20]
Kotliar, D.; Lin, A.E.; Logue, J.; Hughes, T.K.; Khoury, N.M.; Raju, S.S.; Wadsworth, M.H., II; Chen, H.; Kurtz, J.R.; Dighero-Kemp, B.; Bjornson, Z.B.; Mukherjee, N.; Sellers, B.A.; Tran, N.; Bauer, M.R.; Adams, G.C.; Adams, R.; Rinn, J.L.; Melé, M.; Schaffner, S.F.; Nolan, G.P.; Barnes, K.G.; Hensley, L.E.; McIlwain, D.R.; Shalek, A.K.; Sabeti, P.C.; Bennett, R.S. Single-cell profiling of ebola virus disease in vivo reveals viral and host dynamics. Cell, 2020, 183(5), 1383-1401.e19.
[http://dx.doi.org/10.1016/j.cell.2020.10.002] [PMID: 33159858]
[21]
Price, A.; Okumura, A.; Haddock, E.; Feldmann, F.; Meade-White, K.; Sharma, P.; Artami, M.; Lipkin, W.I.; Threadgill, D.W.; Feldmann, H.; Rasmussen, A.L. Transcriptional correlates of tolerance and lethality in mice predict Ebola virus disease patient outcomes. Cell Rep., 2020, 30(6), 1702-1713.e6.
[http://dx.doi.org/10.1016/j.celrep.2020.01.026] [PMID: 32049004]
[22]
Toroghi, M.K.; Al-Huniti, N.; Davis, J.D.; DiCioccio, A.T.; Rippley, R.; Baum, A.; Kyratsous, C.A.; Sivapalasingam, S.; Kantrowitz, J.; Kamal, M.A. A drug‐disease model for predicting survival in an Ebola outbreak. Clin. Transl. Sci., 2022, 15(10), 2538-2550.
[http://dx.doi.org/10.1111/cts.13383] [PMID: 35895082]
[23]
Oza, S.; Sesay, A.A.; Russell, N.J.; Wing, K.; Boufkhed, S.; Vandi, L.; Sebba, S.C.; Cummings, R.; Checchi, F. Symptom-and laboratory-based Ebola risk scores to differentiate likely Ebola infections. Emerg. Infect. Dis., 2017, 23(11), 1792-1799.
[http://dx.doi.org/10.3201/eid2311.170171] [PMID: 29047428]
[24]
Smither, S.; O’Brien, L.; Eastaugh, L.; Woolley, T.; Lever, M.; Fletcher, T.; Parmar, K.; Hunt, B.; Watts, S.; Kirkman, E. Haemostatic changes in five patients infected with Ebola virus. Viruses, 2019, 11(7), 647.
[http://dx.doi.org/10.3390/v11070647] [PMID: 31311112]
[25]
Fontes, C.M.; Lipes, B.D.; Liu, J.; Agans, K.N.; Yan, A.; Shi, P.; Cruz, D.F.; Kelly, G.; Luginbuhl, K.M.; Joh, D.Y.; Foster, S.L.; Heggestad, J.; Hucknall, A.; Mikkelsen, M.H.; Pieper, C.F.; Horstmeyer, R.W.; Geisbert, T.W.; Gunn, M.D.; Chilkoti, A. Ultrasensitive point-of-care immunoassay for secreted glycoprotein detects Ebola infection earlier than PCR. Sci. Transl. Med., 2021, 13(588), eabd9696.
[http://dx.doi.org/10.1126/scitranslmed.abd9696] [PMID: 33827978]
[26]
Lee, J.E.; Saphire, E.O. Ebolavirus glycoprotein structure and mechanism of entry. Future Virol., 2009, 4(6), 621-635.
[http://dx.doi.org/10.2217/fvl.09.56] [PMID: 20198110]
[27]
Dahlmann, F.; Biedenkopf, N.; Babler, A.; Jahnen-Dechent, W.; Karsten, C.B.; Gnirß, K. Analysis of ebola virus entry into macrophages. J. Infect. Dis., 2015, 2(S2), S247-S257.
[28]
Usami, K.; Matsuno, K.; Igarashi, M.; Denda-Nagai, K.; Takada, A.; Irimura, T. Involvement of viral envelope GP2 in Ebola virus entry into cells expressing the macrophage galactose-type C-type lectin. Biochem. Biophys. Res. Commun., 2011, 407(1), 74-78.
[http://dx.doi.org/10.1016/j.bbrc.2011.02.110] [PMID: 21362405]
[29]
Jain, S.; Martynova, E.; Rizvanov, A.; Khaiboullina, S.; Baranwal, M. Structural and functional aspects of Ebola virus proteins. Pathogens, 2021, 10(10), 1330.
[http://dx.doi.org/10.3390/pathogens10101330] [PMID: 34684279]
[30]
Bradley, J.H.; Harrison, A.; Corey, A.; Gentry, N.; Gregg, R.K. Ebola virus secreted glycoprotein decreases the anti-viral immunity of macrophages in early inflammatory responses. Cell. Immunol., 2018, 324, 24-32.
[http://dx.doi.org/10.1016/j.cellimm.2017.11.009] [PMID: 29195741]
[31]
Escudero-Pérez, B.; Volchkova, V.A.; Dolnik, O.; Lawrence, P.; Volchkov, V.E. Shed GP of Ebola virus triggers immune activation and increased vascular permeability. PLoS Pathog., 2014, 10(11), e1004509.
[http://dx.doi.org/10.1371/journal.ppat.1004509] [PMID: 25412102]
[32]
Feldmann, H.; Nichol, S.T.; Klenk, H.D.; Peters, C.J.; Sanchez, A. Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology, 1994, 199(2), 469-473.
[http://dx.doi.org/10.1006/viro.1994.1147] [PMID: 8122375]
[33]
Yuan, B.; Peng, Q.; Cheng, J.; Wang, M.; Zhong, J.; Qi, J.; Gao, G.F.; Shi, Y. Structure of the Ebola virus polymerase complex. Nature, 2022, 610(7931), 394-401.
[http://dx.doi.org/10.1038/s41586-022-05271-2] [PMID: 36171293]
[34]
dos Santos, N.I.J.; da Silva, S.P.F.; de Araújo-Júnior, J.X.; da Silva-Júnior, E.F. Strategies in medicinal chemistry to discover new hit compounds against Ebola virus: Challenges and perspectives in drug discovery. Mini Rev. Med. Chem., 2022, 22(22), 2896-2924.
[http://dx.doi.org/10.2174/1389557522666220404085858] [PMID: 35379146]
[35]
McElroy, A.K.; Akondy, R.S.; Mcllwain, D.R.; Chen, H.; Bjornson-Hooper, Z.; Mukherjee, N.; Mehta, A.K.; Nolan, G.; Nichol, S.T.; Spiropoulou, C.F. Immunologic timeline of Ebola virus disease and recovery in humans. JCI Insight, 2020, 5(10), e137260.
[http://dx.doi.org/10.1172/jci.insight.137260] [PMID: 32434986]
[36]
Scherm, M.J.; Gangloff, M.; Gay, N.J. Activation of Toll-like receptor 4 by Ebola virus-shed glycoprotein is direct and requires the internal fusion loop but not glycosylation. Cell Rep., 2022, 41(4), 111562.
[http://dx.doi.org/10.1016/j.celrep.2022.111562] [PMID: 36288690]
[37]
Rao, D.; O’Donnell, K.L.; Carmody, A.; Weissman, I.L.; Hasenkrug, K.J.; Marzi, A. CD47 expression attenuates Ebola virus-induced immunopathology in mice. Antiviral Res., 2022, 197, 105226.
[http://dx.doi.org/10.1016/j.antiviral.2021.105226] [PMID: 34923028]
[38]
Colavita, F.; Biava, M.; Castilletti, C.; Lanini, S.; Miccio, R.; Portella, G.; Vairo, F.; Ippolito, G.; Capobianchi, M.R.; Di Caro, A.; Lalle, E. Inflammatory and humoral immune response during Ebola virus infection in survivor and fatal cases occurred in Sierra Leone during the 2014-2016 outbreak in West Africa. Viruses, 2019, 11(4), 373.
[http://dx.doi.org/10.3390/v11040373] [PMID: 31018522]
[39]
Bixler, S.; Goff, A. The role of cytokines and chemokines in filovirus infection. Viruses, 2015, 7(10), 5489-5507.
[http://dx.doi.org/10.3390/v7102892] [PMID: 26512687]
[40]
Coller, B.A.G.; Lapps, W., Jr; Yunus, M.; Bruno, S.; Eichberg, M.J.; Lee, A.W.T.; Liu, K.; Drury, R.; Millogo, J.; Macareo, L.R.; Armstrong, T.H.; Blue, J.T.; Isopi, L.A.; Hughes, M.; VanRheenen, S.M.; Deutsch, J.; Tell, J.G.; Dubey, S.A. Lessons learned from the development and roll-out of the rVSVΔG-ZEBOV-GP Zaire ebolavirus vaccine to inform Marburg virus and Sudan ebolavirus vaccines. Vaccines, 2022, 10(9), 1446.
[http://dx.doi.org/10.3390/vaccines10091446] [PMID: 36146524]
[41]
Rose, N.F.; Buonocore, L.; Schell, J.B.; Chattopadhyay, A.; Bahl, K.; Liu, X.; Rose, J.K. In vitro evolution of high-titer, virus-like vesicles containing a single structural protein. Proc. Natl. Acad. Sci., 2014, 111(47), 16866-16871.
[http://dx.doi.org/10.1073/pnas.1414991111] [PMID: 25385608]
[42]
Beier, K.T.; Saunders, A.B.; Oldenburg, I.A.; Sabatini, B.L.; Cepko, C.L. Vesicular stomatitis virus with the rabies virus glycoprotein directs retrograde transsynaptic transport among neurons in vivo. Front. Neural Circuits, 2013, 7(JAN), 11.
[http://dx.doi.org/10.3389/fncir.2013.00011] [PMID: 23403489]
[43]
Liu, G.; Cao, W.; Salawudeen, A.; Zhu, W.; Emeterio, K.; Safronetz, D.; Banadyga, L. Vesicular stomatitis virus: From agricultural pathogen to vaccine vector. Pathogens, 2021, 10(9), 1092.
[http://dx.doi.org/10.3390/pathogens10091092] [PMID: 34578125]
[44]
Ryder, A.B.; Nachbagauer, R.; Buonocore, L.; Palese, P.; Krammer, F.; Rose, J.K. Vaccination with vesicular stomatitis virus-vectored chimeric hemagglutinins protects mice against divergent influenza virus challenge strains. J. Virol., 2016, 90(5), 2544-2550.
[http://dx.doi.org/10.1128/JVI.02598-15] [PMID: 26676789]
[45]
Branswell, H. Ebola War. Sci. Am., 2015, 312(3), 48-55.
[http://dx.doi.org/10.1038/scientificamerican0315-48]
[46]
Garbutt, M.; Liebscher, R.; Wahl-Jensen, V.; Jones, S.; Möller, P.; Wagner, R.; Volchkov, V.; Klenk, H.D.; Feldmann, H.; Ströher, U. Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J. Virol., 2004, 78(10), 5458-5465.
[http://dx.doi.org/10.1128/JVI.78.10.5458-5465.2004] [PMID: 15113924]
[47]
Farzani, T.A.; Chov, A.; Herschhorn, A. A protocol for displaying viral envelope glycoproteins on the surface of vesicular stomatitis viruses. STAR Protocols, 2020, 1(3), 100209.
[http://dx.doi.org/10.1016/j.xpro.2020.100209] [PMID: 33377103]
[48]
Rodriguez, L.L.; De Roo, A.; Guimard, Y.; Trappier, S.G.; Sanchez, A.; Bressler, D.; Williams, A.J.; Rowe, A.K.; Bertolli, J.; Khan, A.S.; Ksiazek, T.G.; Peters, C.J.; Nichol, S.T. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, democratic republic of the congo, 1995. J. Infect. Dis., 1999, 179(s1)c(Suppl. 1), S170-S176.
[http://dx.doi.org/10.1086/514291] [PMID: 9988181]
[49]
Gélinas, J.F.; Kiesslich, S.; Gilbert, R.; Kamen, A.A. Titration methods for rVSV-based vaccine manufacturing. MethodsX, 2020, 7, 100806.
[http://dx.doi.org/10.1016/j.mex.2020.100806] [PMID: 32195130]
[50]
Kiesslich, S.; Vila-Chã Losa, J.P.; Gélinas, J.F.; Kamen, A.A. Serum-free production of rVSV-ZEBOV in Vero cells: Microcarrier bioreactor versus scale-X™ hydro fixed-bed. J. Biotechnol., 2020, 310, 32-39.
[http://dx.doi.org/10.1016/j.jbiotec.2020.01.015] [PMID: 32006630]
[51]
Lichty, B.D.; Power, A.T.; Stojdl, D.F.; Bell, J.C. Vesicular stomatitis virus: Re-inventing the bullet. Trends Mol. Med., 2004, 10(5), 210-216.
[http://dx.doi.org/10.1016/j.molmed.2004.03.003] [PMID: 15121047]
[52]
Ishola, D.; Manno, D.; Afolabi, M.O.; Keshinro, B.; Bockstal, V.; Rogers, B.; Owusu-Kyei, K.; Serry-Bangura, A.; Swaray, I.; Lowe, B.; Kowuor, D.; Baiden, F.; Mooney, T.; Smout, E.; Köhn, B.; Otieno, G.T.; Jusu, M.; Foster, J.; Samai, M.; Deen, G.F.; Larson, H.; Lees, S.; Goldstein, N.; Gallagher, K.E.; Gaddah, A.; Heerwegh, D.; Callendret, B.; Luhn, K.; Robinson, C.; Leyssen, M.; Greenwood, B.; Douoguih, M.; Leigh, B.; Watson-Jones, D.; Kargbo, M.; Bockarie, E.; James, N.L.; Kabbah, A.; Kamara, A.; Koroma, K.H.; Langley, S.O.; William, N.; Kessebeh, R.; Mooney, T.; Conteh, L.; Smout, E.; Allieu, K.; Bangura, K.; Bangura, M.S.; Bangura, M.A.; Jalloh, H.; Jalloh, A.B.; Kamara, I.; Kamara, M.; Konteh, A.; Koroma, S.; Marrah, C.; Sesay, M.; Sesay, M.T.; Deen, A.T.; Jalloh, A.; Kaimbay, R.M.; Kain, D.; Kamara, A.; Kamara, E.L.; Kamara, M.P.; Kamara, O.J.; Kamara, I.; Kamara, S.L.M.; Kanneh, M.; Koroma, A.H.; Lahai, D.; Mansaray, I.S.; Marah, W.S.; Massaquoi, M.J.; Nabie, A.; Saidu, N.S.; Samai, I.; Tengheh, J.N.; Turay, A.S.; Fornah, A.; Sesay, F.; Sow, A.; Swaray, E.; Mansaray, F.; Ade-Cole, T.; Bangura, L.M.; Conteh, M.L.; Kabbah, A.; Koroma, A.M.; Koroma, M.; Sam, A.; Scott, T.; Sessie, T.; Sunders, J-H.C.; Turay, S.I-S.; Weekes, J.; Sheku, M.; Gibson, L.; Kowuor, D.; Ahamed, I.; Allieu, W.; Kabba, D.U.; Kamara, F.J.; Kebbie, M.S.; Pessima, M.; Wurie, A.; Bah, F.; Bangura, A.I.; Bangura, R A S.; Blango, L.; Boima, S.; Conteh, M.; Conteh, Y.; Daramy, M.L.; Fofanah, O.; George, E.; Hanson, T.F.; Jalloh, M.I.; Kalawa, M.; Kamara, A.M.; Kamara, F.E.; Kamara, G.M.; Kamara, H.M.; Kamara, P.B.D.; Kamara, R.T.; Kamara, R.; Kanneh, D.P.; Kanneh, M.; Komeh, I.; Koroma, M.; Kuyateh, M.; Mansaray, F.F.; Mansaray, M.M.; Sillah, A.B.; Tarawally, M.A.; Turya, O.S.; Yawmah, J.B.; Leigh, B.; Watson-Jones, D.; Greenwood, B.; Samai, M.H.; Deen, G.F.; Marke, D.; Piot, P.; Smith, P.; Edmunds, J.; Lees, S.; Larson, H.; Weiss, H.; Wilson, P.; Maxwell, C.; Ishola, D.; Afolabi, M.; Baiden, F.; Akoo, P.; Owusu-Kyei, K.; Tindanbil, D.; Bower, H.; Stuart, J.; Bah, O.M.; Rogers, B.T.; Serry-Bangura, A.; Swaray, I.B.; Bangura, A.; David, I.J.; Davies, D.G.M.; Kallon, J.A.; Kamara, A.B.; Kamara, I.F.; Kamara, M.M.; Morovia, F.E.; Suma, F.B.; Thompson, F.; Murray, M.; Sesay, F.; Sesay, I.; Kakay, O.; Suma, F.; Foster, J.; Philips, R.; Manno, D.; Gallager, K.; Cox, S.; Howard, N.; Cesay, M.; Torrani, P.; Sharma, S.; Snowden, E.; Banks, T.; Harber, T.; Brown, J.; Howard, K.; Melton, N.; Malcolm, S.; Welsh, S.; Eggo, R.; Jendrossek, M.; Pearson, C.; Van Hoof, J.; Douoguih, M.; Offergelt, K.; Robinson, C.; Keshinro, B.; Van Alst, M.; Mahajan, N.; Bockstal, V.; Goldstein, N.; Gaddah, A.; Heerwegh, D.; Luhn, K.; Leyssen, M.; Lowe, B.; Awuondo, K.; Hafezi, H.; Hancox, E.; Kohn, B.; Tuda, G.O.; Koroma, F.; Kamara, A.; Bangura, G.; Kroma, M.T.; Fofanah, L.; Pessima, A.; Rogers, M.; Sheriff, O.; Ajala, T.W.; Fangawa, J.; Foday, S., Jr; Jabbie, I.; Mansaray, B.; Mansaray, H.A.; Sesay, K.; Charles, M.K.; Heroe, P.C.; Karbo, M.L.; Yansaneh, I.S.; Egoeh, S.G.; Trye, A.; Amponsah, M.; Alghali, N.D.; Bah, A.; Bangura, I.J.; Cole, A.C.; Fofanah, K.; Fofanah, S.; Jalloh, H.U.; Jalloh, K F N.; Jalloh, N.; Kabba, H.U.; Kabba, J.N.; Kabba, M.; Kamara, R.; Kamara, J.S.; Kanjie, F.; Kanu, A.P.; Kargbo, I.; Kassa-Koroma, G.; Koroma, S.B.; Sankoh, A.; Sankoh, T.; Sesay, O.D.; Wilhem, H.; Williams, C.T.; Bangura, I.; Ben-Rogers, Y.; Jalloh, A.; Jamboria, F.J.; Kamara, N.; Kanawah, I.; Kargbo, A.T.; Swaray, I.; Amara, L.; Bundu, I.; Jakema, H.B.; Kamara, K.; Sheku, M.F.; Adeleye, Q.; Akhigbe, I.; Bakalemwa, R.; Chami, N.P.; Sylvester, T.; Altmann, L.; Kamara, B.; van Roey, K.; Conteh, P.; Samura, M.; Gandie, V.; Marrah, M.; Moinina, E.; Kalokoh, J.; Bangura, M.I.; Bosompem, S.; Hilton, T.; Jusu, M.O.; Borboh, P.; Brima, A.S.; Caulker, A F Y.; Kallon, A.; Koroma, B.; Macauley, R.C.; Saquee, T.M.D.; Williams, H.I.; Bangura, A.R.; Fornah, J.; Idriss, B.; Sillah, M.; Mackay, W.; Aleghen, B.; Murray, T.; Edem-Hotah, J.; Fatorma, T.; Amara, F.; Kamara, M.; Bangura, S.; Bonnie, E.; Sannoh, M.; Donaldson, A.; Ndingi, S.; Nyaberi, D.; Pereira, M.; Rothwell, A.; Vy, V.; Nyallay, L.; Fombah, A.; Saidu, S.; Hancox, E.; Connor, N.; Dambo, T.P.; Fakaba, P.J.; Fatorma, M.M.E.; Johnson, C.L.; Kamara, M.; Kogba, D.B.; Lahai, A.; Vincent, W.; Yambasu, N.; Bangura, M.; Tengbeh, A.; Bangura, K.; Kabia, R.; Nyakoi, A.M.; Callaghan, M.; Enria, L.; Lee, S. Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: A combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial. Lancet Infect. Dis., 2022, 22(1), 97-109.
[http://dx.doi.org/10.1016/S1473-3099(21)00125-0] [PMID: 34529963]
[53]
Wagstaffe, H.R.; Clutterbuck, E.A.; Bockstal, V.; Stoop, J.N.; Luhn, K.; Douoguih, M.; Shukarev, G.; Snape, M.D.; Pollard, A.J.; Riley, E.M.; Goodier, M.R. Ebola virus glycoprotein stimulates IL-18-dependent natural killer cell responses. J. Clin. Invest., 2020, 130(7), 3936-3946.
[http://dx.doi.org/10.1172/JCI132438] [PMID: 32315287]
[54]
Raabe, V.; Lai, L.; Morales, J.; Xu, Y.; Rouphael, N.; Davey, R.T.; Mulligan, M.J. Cellular and humoral immunity to Ebola Zaire glycoprotein and viral vector proteins following immunization with recombinant vesicular stomatitis virus-based Ebola vaccine (rVSVΔG-ZEBOV-GP). Vaccine, 2023, 41(8), 1513-1523.
[http://dx.doi.org/10.1016/j.vaccine.2023.01.059] [PMID: 36725433]
[55]
Pollard, A.J.; Launay, O.; Lelievre, J.D.; Lacabaratz, C.; Grande, S.; Goldstein, N.; Robinson, C.; Gaddah, A.; Bockstal, V.; Wiedemann, A.; Leyssen, M.; Luhn, K.; Richert, L.; Bétard, C.; Gibani, M.M.; Clutterbuck, E.A.; Snape, M.D.; Levy, Y.; Douoguih, M.; Thiebaut, R.; McShane, C.; Callendret, B.; Dincq, S.; Ferrault, C.; Chai, S.P.; Gyselen, M.P.; van Looveren, M.; van Ballert, S.; de Cnodder, T.; Roza, L.; Forcheh, C.; Stevens, K.; Mastrandrea, C.; de Ridder, S.; Gundluru, R.; Swales, N.; Errijegers, V.; Willems, W.; Roorda, V.; Orzabal, N.; Assenberg, M.; Vialatte, K.; Remblier, F.; Porcar, E.; Ottavi, A.; Destandau, E.; Schwimmer, C.; Moinot, L.; Wallet, C.; Allais, F.; Savel, H.; Nedjaai, N.; Maugard, A.; Lenzi, N.; Loulergue, P.; Bahuaud, M.; Lainé, F.; Laviolle, B.; Boissel, N.; Thébault, E.; Vallée, D.; Nicolas, J-F.; Gilbert, S.; Dahel, K.; Sagorny, K.; Lucht, F.; Paul, S.; Haccourt Chanavat, A.; Charra, F.; Mutter, C.; Lambour, M.; Muller, C.; Hutt-Clauss, A.; Aranda, O.; Bernard, L.; Gissot, V.; Hallouin-Bernard, M-C.; Goudeau, A.; Suzzoni, S.; Auostin, E.; Brick, L.; Lopez-Zaragoza, J-L.; Melic, G.; Carvalho, M.; Chesnel, C.; Hocini, H.; Wiedemann, A.; Hanot, L.; Rieux, V.; Puri, A.; Adeloye, T.; Boyce, M.; Dennison, J.; Loewenstein, I.; Sahgal, O.; van den Berg, F.; Calvert, W.; Faldon, M.; McClain, B.; Newell, M-L.; Molenberghs, G. Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): A randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial. Lancet Infect. Dis., 2021, 21(4), 493-506.
[http://dx.doi.org/10.1016/S1473-3099(20)30476-X] [PMID: 33217361]
[56]
Afolabi, M.O.; Ishola, D.; Manno, D.; Keshinro, B.; Bockstal, V.; Rogers, B.; Owusu-Kyei, K.; Serry-Bangura, A.; Swaray, I.; Lowe, B.; Kowuor, D.; Baiden, F.; Mooney, T.; Smout, E.; Köhn, B.; Otieno, G.T.; Jusu, M.; Foster, J.; Samai, M.; Deen, G.F.; Larson, H.; Lees, S.; Goldstein, N.; Gallagher, K.E.; Gaddah, A.; Heerwegh, D.; Callendret, B.; Luhn, K.; Robinson, C.; Greenwood, B.; Leyssen, M.; Douoguih, M.; Leigh, B.; Watson-Jones, D.; Kargbo, M.; Bockarie, E.; James, N.L.; Kabbah, A.; Kamara, A.; Koroma, K.H.; Langley, S.O.; William, N.; Kessebeh, R.; Mooney, T.; Conteh, L.; Smout, E.; Allieu, K.; Bangura, K.; Bangura, M.S.; Bangura, M.A.; Jalloh, H.; Jalloh, A.B.; Kamara, I.; Kamara, M.; Konteh, A.; Koroma, S.; Marrah, C.; Sesay, M.; Sesay, M.T.; Deen, A.T.; Jalloh, A.; Kaimbay, R.M.; Kain, D.; Kamara, A.; Kamara, E.L.; Kamara, M.P.; Kamara, O.J.; Kamara, I.; Kamara, S.L.M.; Kanneh, M.; Koroma, A.H.; Lahai, D.; Mansaray, I.S.; Marah, W.S.; Massaquoi, M.J.; Nabie, A.; Saidu, N.S.; Samai, I.; Tengheh, J.N.; Turay, A.S.; Fornah, A.; Sesay, F.; Sow, A.; Swaray, E.; Mansaray, F.; Ade-Cole, T.; Bangura, L.M.; Conteh, M.L.; Kabbah, A.; Koroma, A.M.; Koroma, M.; Sam, A.; Scott, T.; Sessie, T.; Sunders, J-H.C.; Turay, S.I-S.; Weekes, J.; Sheku, M.; Gibson, L.; Kowuor, D.; Ahamed, I.; Allieu, W.; Kabba, D.U.; Kamara, F.J.; Kebbie, M.S.; Pessima, M.; Wurie, A.; Bah, F.; Bangura, A.I.; Bangura, R A S.; Blango, L.; Boima, S.; Conteh, M.; Conteh, Y.; Daramy, M.L.; Fofanah, O.; George, E.; Hanson, T.F.; Jalloh, M.I.; Kalawa, M.; Kamara, A.M.; Kamara, F.E.; Kamara, G.M.; Kamara, H.M.; Kamara, P.B.D.; Kamara, R.T.; Kamara, R.; Kanneh, D.P.; Kanneh, M.; Komeh, I.; Koroma, M.; Kuyateh, M.; Mansaray, F.F.; Mansaray, M.M.; Sillah, A.B.; Tarawally, M.A.; Turya, O.S.; Yawmah, J.B.; Leigh, B.; Watson-Jones, D.; Greenwood, B.; Samai, M.H.; Deen, G.F.; Marke, D.; Sesay, T.; Piot, P.; Smith, P.; Edmunds, J.; Lees, S.; Larson, H.; Weiss, H.; Wilson, P.; Phillips, R.; Maxwell, C.; Ishola, D.; Afolabi, M.; Baiden, F.; Akoo, P.; Owusu-Kyei, K.; Tindanbil, D.; Bower, H.; Stuart, J.; Bah, O.M.; Rogers, B.T.; Serry-Bangura, A.; Swaray, I.B.; Bangura, A.; David, I.J.; Davies, D.G.M.; Kallon, J.A.; Kamara, A.B.; Kamara, I.F.; Kamara, M.M.; Morovia, F.E.; Suma, F.B.; Thompson, F.; Murray, M.; Sesay, F.; Kakay, O.; Suma, F.; Sesay, I.; Foster, J.; Phillips, R.; Manno, D.; Gallagher, K.; Cox, S.; Howard, N.; Cesay, M.; Torrani, P.; Sharma, S.; Snowden, E.; Banks, T.; Harber, T.; Brown, J.; Howard, K.; Melton, N.; Malcolm, S.; Welsh, S.; Eggo, R.; Jendrossek, M.; Pearson, C.; Offergeld, K.; Ferrault, C.; Van Alst, M.; Mahajan, N.; Van Looveren, M.; Van Ballaert, S.; De Cnodder, T.; Grobler, N.; Roza, L.; Liberi, T.; Armishaw, L.; Verkleij, C.; Henrick, T.; Banaszkiewicz, A.; Lowe, B.; Awuondo, K.; Hafezi, H.; Hancox, E.; Kohn, B.; Tuda, G.O.; Kamara, A.; Bangura, G.; Kroma, M.T.; Fofanah, L.; Pessima, A.; Rogers, M.; Sheriff, O.; Ajala, T.W.; Fangawa, J.; Foday, S., Jr; Koroma, I.S.F.; Mansaray, B.; Mansaray, H.A.; Sesay, K.; Charles, M.K.; Heroe, P.C.; Lamin Karbo, M.; Yansaneh, I.S.; Gogo Egoeh, S.; Trye, A.; Amponsah, M.; Donelson, L.; Sylvester, T.; Owira, V.; Onyuka, G.; Nambuchi, L.; Oburu, A.; Apollo, D.; Vandi, L.; Alghali, N.D.; Bah, A.; Bangura, I.J.; Cole, A.C.; Fofanah, S.; Jalloh, H.U.; Jalloh, K F N.; Jalloh, N.; Kabba, H.U.; Kabba, J.N.; Kabba, M.; Kamara, R.; Kamara, J.S.; Kanjie, F.; Kanu, A.P.; Kargbo, I.; Kassa-Koroma, G.; Koroma, S.B.; Sankoh, A.; Sankoh, T.; Sesay, O.D.; Wilhem, H.; Williams, C.T.; Bangura, I.; Ben-Rogers, Y.; Jalloh, A.; Jamboria, F.J.; Kamara, N.; Kanawah, I.; Kargbo, A.T.; Swaray, I.; Amara, L.; Bundu, I.; Jakema, H.B.; Kamara, K.; Sheku, M.F.; Adeleye, Q.; Akhigbe, I.; Bakalemwa, R.; Chami, N.P.; Sylvester, T.; Altmann, L.; Kamara, B.; van Roey, K.; Conteh, P.; Samura, M.; Gandie, V.; Marrah, M.; Moinina, E.; Kalokoh, J.; Bangura, I.; Bosompem, S.; Hilton, T.; Jusu, M.O.; Borboh, P.; Brima, A.S.; Caulker, A F Y.; Kallon, A.; Koroma, B.; Macauley, R.C.; Saquee, T.M.D.; Williams, H.I.; Bangura, A.R.; Fornah, J.; Idriss, B.; Sillah, M.; Mackay, W.; Aleghen, B.; Murray, T.; Edem-Hotah, J.; Fatorma, T.; Amara, F.; Kamara, M.; Bangura, S.; Bonnie, E.; Sannoh, M.; Donaldson, A.; Ndingi, S.; Nyaberi, D.; Pereira, M.; Rothwell, A.; Vy, V.; Nyallay, L.; Fombah, A.; Saidu, S.; Hancox, E.; Dambo, T.P.; Fakaba, P.J.; Fatorma, M.M.E.; Freeman, R.H.; Johnson, C.L.; Kamara, M.; Kogba, D.B.; Lahai, A.; Vincent, W.; Yambasu, N.; Bangura, M.; Tengbeh, A.; Bangura, K.; Kabia, R.; Nyakoi, A.M.; Callaghan, M.; Enria, L.; Lee, S. Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: A randomised, double-blind, controlled trial. Lancet Infect. Dis., 2022, 22(1), 110-122.
[http://dx.doi.org/10.1016/S1473-3099(21)00128-6] [PMID: 34529962]
[57]
Vianello, E.; Gonzalez-Dias, P.; van Veen, S.; Engele, C.G.; Quinten, E.; Monath, T.P.; Medaglini, D.; Santoro, F.; Huttner, A.; Dubey, S.; Eichberg, M.; Ndungu, F.M.; Kremsner, P.G.; Essone, P.N.; Agnandji, S.T.; Siegrist, C.A.; Nakaya, H.I.; Ottenhoff, T.H.M.; Haks, M.C.; Agnandij, S.T.; Ahmed, R.; Anderson, J.; Auderset, F.; Bejon, P.; Borgianni, L.; Brosnahan, J.; Ciabattini, A.; Engler, O.; Haks, M.C.; Harandi, A.M.; Heppner, D.G.; Gerlini, A.; Huttner, A.; Kremsner, P.G.; Medaglini, D.; Monath, T.P.; Ndungu, F.M.; Njuguna, P.; Ottenhoff, T.H.M.; Pejoski, D.; Page, M.; Pozzi, G.; Santoro, F.; Siegrist, C-A.; Agnandij, S.T.; Borgianni, L.; Ciabattini, A.; Dubey, S.; Eichberg, M.; Engler, O.; Ndong, E.P.; Harandi, A.M.; Gerlini, A.; Huttner, A.; Kremsner, P.G.; Lumeka, K.; Medaglini, D.; Nakaya, H.I.; Gonzales, D.C.P.; Ottenhoff, T.H.M.; Pozzi, G.; Rothenberger, S.; Santoro, F.; Siegrist, C-A.; Vianello, E.; Nakka, S.S.; Haks, M.C.; van Veen, S. Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: A molecular biomarker study. Lancet Microbe, 2022, 3(2), e113-e123.
[http://dx.doi.org/10.1016/S2666-5247(21)00235-4] [PMID: 35544042]
[58]
Huttner, A.; Dayer, J.A.; Yerly, S.; Combescure, C.; Auderset, F.; Desmeules, J.; Eickmann, M.; Finckh, A.; Goncalves, A.R.; Hooper, J.W.; Kaya, G.; Krähling, V.; Kwilas, S.; Lemaître, B.; Matthey, A.; Silvera, P.; Becker, S.; Fast, P.E.; Moorthy, V.; Kieny, M.P.; Kaiser, L.; Siegrist, C.A. The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: A randomised double-blind, placebo-controlled phase 1/2 trial. Lancet Infect. Dis., 2015, 15(10), 1156-1166.
[http://dx.doi.org/10.1016/S1473-3099(15)00154-1] [PMID: 26248510]
[59]
Pejoski, D.; de Rham, C.; Martinez-Murillo, P.; Santoro, F.; Auderset, F.; Medaglini, D.; Pozzi, G.; Vono, M.; Lambert, P.H.; Huttner, A.; Haks, M.C.; Ottenhoff, T.H.M.; Villard, J.; Siegrist, C.A.; Addo, M.M.; Agnandji, S.T.; Becker, S.; Bejon, P.; Brosnahan, J.S.; Fast, P.; Huttner, A.; Krähling, V.; Kieny, M-P.; Kremsner, P.G.; Krishna, S.; Lapujade, O.; Moorthy, V.; Njuguna, P.; Savarese, B.; Siegrist, C-A.; Agnandji, S.T.; Ahmed, R.; Anderson, J.; Auderset, F.; Bejon, P.; Borgianni, L.; Brosnahan, J.S.; Ciabattini, A.; Engler, O.; Haks, M.C.; Harandi, A.M.; Heppner, D.G.; Gerlini, A.; Huttner, A.; Kremsner, P.G.; Martinez-Murillo, P.; Medaglini, D.; Monath, T.; Ndungu, F.; Njuguna, P.; Ottenhoff, T.H.M.; Page, M.; Pejoski, D.; Pozzi, G.; Santoro, F.; Siegrist, C-A.; Agnandji, S.T.; Anderson, J.; Auderset, F.; Borgianni, L.; Ciabattini, A.; Dubey, S.; Engler, O.; Fernandes, J.F.; Haks, M.C.; Harandi, A.M.; Gerlini, A.; Huttner, A.; Kremsner, P.G.; Martinez-Murillo, P.; Medaglini, D.; Monath, T.; Nakaya, H.; O’Rourke, F.; Ottenhoff, T.H.M.; Pejoski, D.; Pozzi, G.; Rothenberger, S.; Santoro, F.; Siegrist, C-A. Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination. NPJ Vaccines, 2020, 5(1), 32.
[http://dx.doi.org/10.1038/s41541-020-0179-4] [PMID: 32337075]
[60]
Mark, K.; Laura, R.; Abdoul, H.B. Randomized trial of vaccines for zaire Ebola virus disease. N. Engl. J. Med., 2022, 387(26), 2411-2424.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy